186 related articles for article (PubMed ID: 38452206)
1. WSB1/2 target chromatin-bound lysine-methylated RelA for proteasomal degradation and NF-κB termination.
Zhang J; Yu Y; Zou X; Du Y; Liang Q; Gong M; He Y; Luo J; Wu D; Jiang X; Sinclair M; Tajkhorshid E; Chen HZ; Hou Z; Zheng Y; Chen LF; Yang XD
Nucleic Acids Res; 2024 May; 52(9):4969-4984. PubMed ID: 38452206
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin ligase HERC3 attenuates NF-κB-dependent transcription independently of its enzymatic activity by delivering the RelA subunit for degradation.
Hochrainer K; Pejanovic N; Olaseun VA; Zhang S; Iadecola C; Anrather J
Nucleic Acids Res; 2015 Nov; 43(20):9889-904. PubMed ID: 26476452
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit.
Yang XD; Huang B; Li M; Lamb A; Kelleher NL; Chen LF
EMBO J; 2009 Apr; 28(8):1055-66. PubMed ID: 19262565
[TBL] [Abstract][Full Text] [Related]
4. Monoubiquitination of nuclear RelA negatively regulates NF-κB activity independent of proteasomal degradation.
Hochrainer K; Racchumi G; Zhang S; Iadecola C; Anrather J
Cell Mol Life Sci; 2012 Jun; 69(12):2057-73. PubMed ID: 22261743
[TBL] [Abstract][Full Text] [Related]
5. p97/VCP promotes Cullin-RING-ubiquitin-ligase/proteasome-dependent degradation of IκBα and the preceding liberation of RelA from ubiquitinated IκBα.
Schweitzer K; Pralow A; Naumann M
J Cell Mol Med; 2016 Jan; 20(1):58-70. PubMed ID: 26463447
[TBL] [Abstract][Full Text] [Related]
6. Functional interplay between acetylation and methylation of the RelA subunit of NF-kappaB.
Yang XD; Tajkhorshid E; Chen LF
Mol Cell Biol; 2010 May; 30(9):2170-80. PubMed ID: 20160011
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha induces RelA degradation via ubiquitination at lysine 195 to prevent excessive nuclear factor-kappaB activation.
Fan Y; Mao R; Zhao Y; Yu Y; Sun W; Song P; Shi Z; Zhang D; Yvon E; Zhang H; Fu S; Yang J
J Biol Chem; 2009 Oct; 284(43):29290-7. PubMed ID: 19706600
[TBL] [Abstract][Full Text] [Related]
8. Methodology to study NF-κB/RelA ubiquitination in vivo.
Li H; Starokadomskyy P; Burstein E
Methods Mol Biol; 2015; 1280():371-81. PubMed ID: 25736761
[TBL] [Abstract][Full Text] [Related]
9. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
10. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.
Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T
Front Immunol; 2020; 11():1559. PubMed ID: 32849529
[TBL] [Abstract][Full Text] [Related]
11. Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling.
Levy D; Kuo AJ; Chang Y; Schaefer U; Kitson C; Cheung P; Espejo A; Zee BM; Liu CL; Tangsombatvisit S; Tennen RI; Kuo AY; Tanjing S; Cheung R; Chua KF; Utz PJ; Shi X; Prinjha RK; Lee K; Garcia BA; Bedford MT; Tarakhovsky A; Cheng X; Gozani O
Nat Immunol; 2011 Jan; 12(1):29-36. PubMed ID: 21131967
[TBL] [Abstract][Full Text] [Related]
12. Regulation of NF-κB activity by competition between RelA acetylation and ubiquitination.
Li H; Wittwer T; Weber A; Schneider H; Moreno R; Maine GN; Kracht M; Schmitz ML; Burstein E
Oncogene; 2012 Feb; 31(5):611-23. PubMed ID: 21706061
[TBL] [Abstract][Full Text] [Related]
13. COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase.
Maine GN; Mao X; Komarck CM; Burstein E
EMBO J; 2007 Jan; 26(2):436-47. PubMed ID: 17183367
[TBL] [Abstract][Full Text] [Related]
14. CSN-associated USP48 confers stability to nuclear NF-κB/RelA by trimming K48-linked Ub-chains.
Schweitzer K; Naumann M
Biochim Biophys Acta; 2015 Feb; 1853(2):453-69. PubMed ID: 25486460
[TBL] [Abstract][Full Text] [Related]
15. MKRN2 is a novel ubiquitin E3 ligase for the p65 subunit of NF-κB and negatively regulates inflammatory responses.
Shin C; Ito Y; Ichikawa S; Tokunaga M; Sakata-Sogawa K; Tanaka T
Sci Rep; 2017 Apr; 7():46097. PubMed ID: 28378844
[TBL] [Abstract][Full Text] [Related]
16. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
Spagnol V; Oliveira CAB; Randle SJ; Passos PMS; Correia CRSTB; Simaroli NB; Oliveira JS; Mevissen TET; Medeiros AC; Gomes MD; Komander D; Laman H; Teixeira FR
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129754. PubMed ID: 33010352
[TBL] [Abstract][Full Text] [Related]
17. GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kappaB/RelA.
Mao X; Gluck N; Li D; Maine GN; Li H; Zaidi IW; Repaka A; Mayo MW; Burstein E
Genes Dev; 2009 Apr; 23(7):849-61. PubMed ID: 19339690
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination.
Geng H; Wittwer T; Dittrich-Breiholz O; Kracht M; Schmitz ML
EMBO Rep; 2009 Apr; 10(4):381-6. PubMed ID: 19270718
[TBL] [Abstract][Full Text] [Related]
19. A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC.
Goldhirsh G; Kravtsova-Ivantsiv Y; Satish G; Ziv T; Brik A; Ciechanover A
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873064
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus 1 E3 ubiquitin ligase ICP0 protein inhibits tumor necrosis factor alpha-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1.
Zhang J; Wang K; Wang S; Zheng C
J Virol; 2013 Dec; 87(23):12935-48. PubMed ID: 24067962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
